Allan Jonathan sold 627 shares of Stoke Therapeutics, Inc. at $26.33 for −$16.5k on Oct 2, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
GENERAL COUNSEL & CORP SEC
GENERAL COUNSEL & CORP SEC
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$16,508.91Shares × reported price
Shares traded
627Common Stock
Price per share
$26.33Reported price. Read footnotes for ranges.
% of reported position traded
2.95%This security and ownership context
Holdings after
20,598Direct
Trade date
Oct 2, 2026Sell
Filed
Oct 2, 2026, 5:37 PM ET0-day reporting delay
Accession
0001966716-26-000014Code S · Transaction 235538
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 21,225 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

STOK price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
STOK · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +19%1w ago −3.2%1d ago +1.5%
Returns since7d −3.4%30d +2.6%90d180d1y

Footnotes in full

F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.